Brief: Ryvu Therapeutics FY Net Loss At 111.4 Mln Zlotys
13/03/2025 05:42
March 13 (Reuters) - Ryvu Therapeutics SA RVU.WA: FY NET LOSS 111.44 MILLION ZLOTYS FY OPERATING REVENUE 102.0 MILLION ZLOTYS FY OPERATING LOSS 122.1 MILLION ZLOTYS Source text: ID:nEM6PCpLla Further company coverage: RVU.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; 48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project